JAMA

Nomi Health Pays Off Medical Debt Valued at More than $225 Million for Americans Burdened by Surprise Billing and High Healthcare Costs

Retrieved on: 
Tuesday, September 21, 2021
General Health, Health, Professional Services, Pharmaceutical, Insurance, Prison, Foundation, MacKenzie Scott, RIP, JAMA, Health, Patient, Collection, Gallup, Income, RIP Medical Debt, Hospital, CEO, COVID, Organic, COVID-19, Research, Public housing, Organization, Vaccination, Health insurance, Pharmaceutical industry, Nomi Health, RIP Medical Debt, NOMI HEALTH, RIP MEDICAL DEBT

The debt relief from Nomi Health is RIP Medical Debt’s largest corporate gift since the organization’s founding in 2014, totaling nearly $2 million to relieve $225 million in medical debt. From the very beginning of the pandemic, Nomi applied its direct healthcare model to deploy COVID-19 vaccine and testing directly to people in hard-to-reach communities across Utah, Colorado, Florida, Nebraska, Iowa and Texas -- from rural towns and agricultural farms to public housing facilities and prisons.

Key Points: 
  • Nomi Health , the direct healthcare company rewiring how healthcare is paid for and delivered, today announced it has partnered with RIP Medical Debt to eradicate more than $225 million in overdue medical bills.
  • Nomis near $2 million contribution to purchase the outstanding debt relieves more than 176,000 Americans across Utah, Florida, Colorado and Nebraska of their debt loads.
  • The money owed had accumulated from surprise billing and high healthcare costs before the pandemicand for some has led to wage garnishment, liens, and other burdensome debt collection tactics.
  • The debt relief from Nomi Health is RIP Medical Debts largest corporate gift since the organizations founding in 2014, totaling nearly $2 million to relieve $225 million in medical debt.

truth® Launches Fake Vape Company "Depression Stick!" To Make A Point

Retrieved on: 
Monday, September 20, 2021
Social media, Clifford Whittingham Beers, Marketing, Clinical trial, Curriculum, Policy, Mental, Depression, JAMA, Smoker, Times Square, Truth, Tobacco, National Council, Student, FDA, Electronic cigarette, Nicotine, Tobacco Master Settlement Agreement, Neon, American Medical Association, JUUL, Culture, Multimedia, Big Tobacco, Herbal cigarette, Sadness, Heart, Mental health, NJOY, Logic, TikTok, CEO, Tobacco industry, Ageing, Blu, Awareness, Risk, Science, Journal, Cereal, View, VP, Learning, Smoking, Anxiety, Vuse

As part of the campaign, truth created a fake vape company called Depression Stick!

Key Points: 
  • As part of the campaign, truth created a fake vape company called Depression Stick!
  • is "proud to be the first e-cigarette company to honestly admit vaping nicotine can amplify feelings of depression and anxiety."
  • His aim: convince them to help promote this new vape product by telling the truth and capitalizing on sadness.
  • truth is part of Truth Initiative, a national public health organization dedicated to achieving a culture where young people reject smoking, vaping, and nicotine.

Japanese-brand Automakers are Investing in the Future of the American Workforce

Retrieved on: 
Thursday, September 16, 2021
Public Policy, Government, Automotive, Automotive Manufacturing, General Automotive, Manufacturing, Labor, Motorcycles, Japan Automobile Manufacturers Association, JAMA, Investment, Industry, Climate change, Aging in the American workforce, Future, British armoured fighting vehicle production during World War II, Employment, Director general, Renewable energy, Japan Automobile Manufacturers Association, Inc. (JAMA), JAMA’s Washington, D.C. office (JAMA USA), JAPAN AUTOMOBILE MANUFACTURERS ASSOCIATION, INC. (JAMA), JAMA’S WASHINGTON, D.C. OFFICE (JAMA USA)

Today, the Japan Automobile Manufacturers Association U.S. office (JAMA USA) released its annual contributions update entitled, Investing in the Future of the American Workforce .

Key Points: 
  • Today, the Japan Automobile Manufacturers Association U.S. office (JAMA USA) released its annual contributions update entitled, Investing in the Future of the American Workforce .
  • Despite a challenging and unprecedented year, cumulative manufacturing investment increased to $55.8 billion, and employment remained steady at 94,960 direct jobs.
  • The release also features numerous examples of Japanese-brand automakers dedication to the future American workforce, technological innovation, environmental leadership, and local community partnerships.
  • Japanese-brand automakers are continuing to create high-quality jobs and support local communities throughout the country, while playing a critical role in keeping the U.S. auto industry globally competitive.

Generations Family Practice Invests in New Technology to Insure Optimal Sanitation Amid COVID Delta Variant Surge

Retrieved on: 
Wednesday, September 15, 2021
Well, Affordable Care Act, CEO, Atmosphere, Medical home, Technology, Filtration, Massachusetts Institute of Technology, Coronavirus, UVC, Doctor of Philosophy, HEPA, Patient, UV, Risk, MIT, GFP, ADB, Safety, Physician, Ambulance, PPE, COVID-19, CMM, Virus, JAMA, COVID, Hospital, Care Act 2014, Operation, Pharmaceutical industry, Medical device, Medicine

Other areas that had the most live virus were surfaces touched by patients, followed by areas near air conditioner inlets.

Key Points: 
  • Other areas that had the most live virus were surfaces touched by patients, followed by areas near air conditioner inlets.
  • Providing continuous floor-unit UVC filtration systems in all exam rooms, which channels air through a small chamber with UV light for sanitation after HEPA filtering.
  • Generations Family Practice, P.A., was established in 2005 in Cary, NC, which has grown from a two-person medical practice to the Patient-Centered Medical Home that it is today.
  • Generations Family Practice offers comprehensive primary medical care, from Well-Baby care to Geriatrics, and everything in between.

Colorado Access Partners with Planned Parenthood of the Rocky Mountains to Implement Behavioral Health Screenings in Hopes of Reducing Related Emergency Department Visits

Retrieved on: 
Monday, September 13, 2021
Topical steroid withdrawal, Health, Lists of diseases, Depression, Doctor of Philosophy, Patient, Rocky Mountains, American Medical Association, Public sector, Medicaid, Parenthood, Psychiatry, PPRM, Suicidal ideation, Multimedia, Planned Parenthood, Partnership, JAMA, Grammatical mood, Organization, Journal, Hospital, Health insurance, Management

DENVER, Sept. 13, 2021 /PRNewswire/ -- Suicidal ideation is one of the top 10 reasons for emergency department (ED) visits among Colorado Access members.

Key Points: 
  • DENVER, Sept. 13, 2021 /PRNewswire/ -- Suicidal ideation is one of the top 10 reasons for emergency department (ED) visits among Colorado Access members.
  • The conclusion is clear: there is an increasing need for behavioral health prevention, screening and intervention, especially during and following public health crises.
  • Colorado Access and Planned Parenthood of the Rocky Mountains (PPRM) are working together to address this issue among vulnerable Coloradans.
  • The teams at Colorado Access and PPRM are hoping this change could ultimately reduce behavioral health related ED visits by finding and addressing depression in its early stages.

PsiloThera, Inc. a Leader in Psychedelic Healthcare Innovation Announces the Filing of U. S. Patents Protecting Its Proprietary Psychedelic Therapeutic Process, Tele-Mental Healthcare & Microdosing Online Platform

Retrieved on: 
Thursday, September 9, 2021

PsiloThers's Tele-MentalHealthcare & Microdosing Platform will provide specialized programs which significantly increase the access to focused-evaluation and life-changing therapy for Veterans, 1st Responders and Patients with treatment resistant mental illnesses.

Key Points: 
  • PsiloThers's Tele-MentalHealthcare & Microdosing Platform will provide specialized programs which significantly increase the access to focused-evaluation and life-changing therapy for Veterans, 1st Responders and Patients with treatment resistant mental illnesses.
  • PsiloThera CEO, John Atanasio states, "PsiloThera's first U.S. Patent filing is just the beginning of our intellectual property portfolio strategy to protect PsiloThera's scientific and medical discoveries, technology breakthroughs & proprietary therapeutic processes."
  • "Also, Mental Health Professionals will greatly benefit by using PsiloThera's Tele-Mental Healthcare & Microdosing Platform to easily refer Patients for psilocybin therapies.
  • "I am absolutely passionate about helping our Vets and 1st Responders as well as partnering with the Mental Health Community."

ProtoStar Foundation Launches Matt Stevenson Junior Tennis Tournament (MSJTT) Series As First To Promote Importance Of Mental Health Among Adolescents

Retrieved on: 
Wednesday, September 8, 2021

SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- The ProtoStar Foundation announced today the launch of the Matt Stevenson Junior Tennis Tournament (MSJTT) Series the first and only junior tennis tournament events in the country to promote the importance of mental health for adolescents.

Key Points: 
  • SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- The ProtoStar Foundation announced today the launch of the Matt Stevenson Junior Tennis Tournament (MSJTT) Series the first and only junior tennis tournament events in the country to promote the importance of mental health for adolescents.
  • Mental health awareness among adolescents is crucial today as the youth mental health crisis continues to grow in the U.S., exacerbated most recently by the pandemic.
  • The inspiration behind the MSJTT Series came from the late Matt Stevenson, a young, generous, and passionate tennis professional who ran successful junior tennis programs in the Washington, D.C. area.
  • The main sponsor of the MSJTT Series is the ProtoStar Foundation, a California nonprofit 501(c)(3) organization based in San Diego.

Zynerba Pharmaceuticals Announces Publication of Results of Phase 2 BELIEVE Open-Label Study of Zygel™ in Children and Adolescents with Developmental and Epileptic Encephalopathies (DEE) in JAMA Network Open

Retrieved on: 
Tuesday, September 7, 2021

The article, titled Safety and tolerability of transdermal cannabidiol gel in children with developmental and epileptic encephalopathies: A nonrandomized controlled trial can be accessed at HERE .

Key Points: 
  • The article, titled Safety and tolerability of transdermal cannabidiol gel in children with developmental and epileptic encephalopathies: A nonrandomized controlled trial can be accessed at HERE .
  • Antiseizure medications are usually administered orally, which can be extremely challenging in children with behavioral and cognitive problems.
  • Forty-eight (48) patients with a mean age of 10.5 years were enrolled in BELIEVE and included in the safety analysis.
  • Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release.

Groundbreaking COVID-19 Blood Donor Seroprevalence Study Illustrates Increase in Population with Antibodies Because of Vaccination

Retrieved on: 
Thursday, September 2, 2021
James Harrison (blood donor), Food and Drug Administration, Journal, COVID-19, Severe acute respiratory syndrome coronavirus 2, Antibody, Blood, Vaccination, American Medical Association, Infection, SAN, Sex, Population, JAMA, Safety, Serology, Multimedia, Research, Vaccine, American Red Cross, CDC, Food, Herd immunity, Health, Immunity, World Red Cross and Red Crescent Day, Pharmaceutical industry

More than 1.5 million samples from blood donations were tested over 11 months, estimating an 83.3% rate for combined infection- and vaccine-induced antibodies, among other observations.

Key Points: 
  • More than 1.5 million samples from blood donations were tested over 11 months, estimating an 83.3% rate for combined infection- and vaccine-induced antibodies, among other observations.
  • The regions covered by the MASS-BD program represent 74% of the U.S. population greater than 16 years old.
  • "The act of donating blood not only helps save lives every day, but it is also providing critical research data to track the pandemic."
  • Those who receive Food and Drug Administration approved or authorized vaccines are eligible to give blood providing they meet other eligibility requirements.

HeartFlow Announces Enrollment of First Three Patients in FUSION Trial

Retrieved on: 
Thursday, September 2, 2021
Medical Supplies, Health, Medical Devices, Hospitals, Clinical Trials, Cardiology, Biotechnology, Erasmus MC, Coronary artery disease, ICA, Muscle tissue, Degenerative disease, Diagnosis, Associate, Stenosis, FFR, National health insurance, Insurance, ICAS, Physician, Addition, Doctor of Philosophy, Moyamoya disease, JAMA, Randomized controlled trial, Heart, Dutch ship Admiraal Tjerk Hiddes De Vries, Fractional flow reserve, Intelligence, CTA, Silicon, Deep learning, Overalls, Â, Safety, Comparison, Patient, Erasmus, 3D, Principal, Chest pain, FACC, Ischemia, University Medical Center Utrecht, Perfusion, UMC, Driessen, Pharmaceutical industry, Medical imaging, the HeartFlow FFRct Analysis, HeartFlow, THE HEARTFLOW FFRCT ANALYSIS, HEARTFLOW

With the FUSION trial, we anticipate a 33% reduction in unnecessary ICAs which we believe will lead to cost savings for the overall healthcare system.

Key Points: 
  • With the FUSION trial, we anticipate a 33% reduction in unnecessary ICAs which we believe will lead to cost savings for the overall healthcare system.
  • The FUSION trial is planned to enroll 528 patients from six Dutch hospitals including Erasmus MC, UMCG, UMC Utrecht, the Admiraal de Ruyter Hospital in Goes, St Jansdal in Lelystad and Gelre hospitals Apeldoorn.
  • Patients whose CTA shows coronary artery disease will be randomized between the HeartFlow FFRct arm or the ICA arm.
  • Once the trial is complete, it is anticipated that the data will support insurance reimbursement in the Netherlands for the HeartFlow Analysis.